Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil.

Instituto Fernandes Figueira115 enrolled

Overview

The study was carried out within a large, urban prospective cohort of PLHIV at the Instituto Nacional de Infectologia Evandro Chagas (INI). Located in Rio de Janeiro, Brazil, INI is a national public referral center for PLWHA receiving primary care since 1998. From December 2019, adults who had attitudes toward quitting smoking and had no contraindications to study pharmacotherapy were enrolled by active site searching

Study Type

OBSERVATIONAL

Enrollment

115

Conditions

Smoking Cessation Brachial Flow Mediated Dilatation Nicotine Replacement Therapy

Interventions

Nicotine replacementDRUG

Nicotine patches

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * individuals were deemed as regular smokers, defined as the consumption of one or more pack (20 cigarettes) per week in the past 6 months, and expired carbon monoxide (CO) measurement \> 10 ppm at the screening visit. Exclusion Criteria: * previous use of transdermal nicotine patches or bupropion in the last 6 months; (ii) contraindication to nicotine patches; (iii). Pregnancy; (iv) breastfeeding

Locations (1)

Instituto Nacional de Infectologia Evandro Chagas

Rio de Janeiro, Brazil

Outcomes

Primary Outcomes

FMD

Flow mediated brachial artery dilatation

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.